Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.
A Randomized, Double Blind, Placebo Controlled, Multicentric Study to Assess the Efficacy and Safety of Udenafil Tablets in Patients Suffering From Erectile Dysfunction.
Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S.
Listed as NCT01305083, this PHASE3 trial focuses on Erectile Dysfunction and remains completed. Sponsored by Abdi Ibrahim Ilac San. ve Tic A.S., it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abdi Ibrahim Ilac San. ve Tic A.S.
For direct contact, visit the study record on ClinicalTrials.gov .